Entries of Lammertz, Sarah E. on the publication server

Paulzen, Michael , Haen, Ekkehard, Hiemke, Christoph, Stegmann, Benedikt, Lammertz, Sarah E., Gründer, Gerhard and Schoretsanitis, Georgios (2017) Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy. British Journal of Clinical Pharmacology 83 (8), pp. 1668-1675. Fulltext not available.

Paulzen, Michael, Schoretsanitis, Georgios , Stegmann, Benedikt, Hiemke, Christoph, Gründer, Gerhard, Schruers, Koen R. J., Walther, Sebastian , Lammertz, Sarah E. and Haen, Ekkehard (2017) Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics. Progress in Neuro-Psychopharmacology and Biological Psychiatry 76, pp. 101-106. Fulltext not available.

Paulzen, Michael , Haen, Ekkehard, Stegmann, Benedikt, Hiemke, Christoph, Gründer, Gerhard, Lammertz, Sarah E. and Schoretsanitis, Georgios (2016) Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis. Psychoneuroendocrinology 73, pp. 9-15. Fulltext not available.

Schoretsanitis, Georgios, Haen, Ekkehard, Gründer, Gerhard, Stegmann, Benedikt, Schruers, Koen R. J., Hiemke, Christoph, Lammertz, Sarah E. and Paulzen, Michael (2016) Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment. Journal of Clinical Psychopharmacology 36 (6), pp. 554-561. Fulltext not available.

Schoretsanitis, Georgios , Stegmann, Benedikt, Hiemke, Christoph, Gründer, Gerhard, Schruers, Koen R. J., Walther, Sebastian , Lammertz, Sarah E., Haen, Ekkehard and Paulzen, Michael (2016) Pharmacokinetic patterns of risperidone-associated adverse drug reactions. European Journal of Clinical Pharmacology 72 (9), pp. 1091-1098. Fulltext not available.

Schoretsanitis, Georgios, Haen, Ekkehard, Hiemke, Christoph, Gründer, Gerhard, Stegmann, Benedikt, Schruers, Koen R. J., Veselinovic, Tanja, Lammertz, Sarah E. and Paulzen, Michael (2016) Risperidone-induced extrapyramidal side effects. International Clinical Psychopharmacology 31 (5), pp. 259-264. Fulltext not available.